ABVC Stock Analysis: Buy, Sell, or Hold?
ABVC - ABVC BioPharma, Inc. Common Stock
$1.07
-0.01 (-0.93%)
▼
5d:
-15.75%
30d:
+7.0%
90d:
-48.06%
HOLD
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When ABVC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ABVC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ABVC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ABVC is currently trading at $1.07, which is considered slightly low relative to its 30-day fair value range of $1.05 to $1.36.
Technical Outlook: Technically, ABVC is in a strong downtrend. Immediate support is located at $1.03, while resistance sits at $1.40.
Market Sentiment: ABVC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.02 (+88.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABVC is in a strong downtrend. Immediate support is located at $1.03, while resistance sits at $1.40.
Market Sentiment: ABVC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.02 (+88.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.05 -
$1.36
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 88.8% below Wall St target ($2.02)
- CAUTION: 5-day price weakness (-15.7%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.05 -
$1.36
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.03
Resistance Level
$1.40
Current Trend
Strong Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Wall Street Target
$2.02
(+88.8%)
Revenue Growth (YoY)
104.5%
Share & Embed Analysis
Last updated: April 29, 2026 4:19 AM ET
Data refreshes hourly during market hours. Next update: 5:19 AM
Data refreshes hourly during market hours. Next update: 5:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABVC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$99 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 55 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
14 analysts |
$57 | 59 HOLD |
